RU93049093A - METHOD OF SAFE INTRAVAL INTRODUCTION OF FATTY ACIDS, METHOD OF APPLICATION OF FATTY ACIDS FOR TREATMENT OF CANCER AND OTHER DISEASES - Google Patents
METHOD OF SAFE INTRAVAL INTRODUCTION OF FATTY ACIDS, METHOD OF APPLICATION OF FATTY ACIDS FOR TREATMENT OF CANCER AND OTHER DISEASESInfo
- Publication number
- RU93049093A RU93049093A RU93049093/14A RU93049093A RU93049093A RU 93049093 A RU93049093 A RU 93049093A RU 93049093/14 A RU93049093/14 A RU 93049093/14A RU 93049093 A RU93049093 A RU 93049093A RU 93049093 A RU93049093 A RU 93049093A
- Authority
- RU
- Russia
- Prior art keywords
- fatty acids
- heparin
- introduction
- diseases
- safe
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims 8
- 239000000194 fatty acid Substances 0.000 title claims 8
- 150000004665 fatty acids Chemical class 0.000 title claims 8
- 201000011510 cancer Diseases 0.000 title claims 2
- 201000010099 disease Diseases 0.000 title claims 2
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Farmotal Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims 2
- 229960002897 Heparin Drugs 0.000 claims 2
- 230000002429 anti-coagulation Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229920000669 heparin Polymers 0.000 claims 2
- 210000002381 Plasma Anatomy 0.000 claims 1
- 206010047461 Viral infection Diseases 0.000 claims 1
- 208000001756 Virus Disease Diseases 0.000 claims 1
- 239000003146 anticoagulant agent Substances 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 230000017613 viral reproduction Effects 0.000 claims 1
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9218065.2 | 1992-08-25 | ||
GB9222655.4 | 1992-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU93049093A true RU93049093A (en) | 1996-06-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0706398A1 (en) | Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters | |
US4794103A (en) | Pharmaceutical compositions containing peptides of the cholecystokinin-cerulein group for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies | |
EP0716611B1 (en) | C1-esterase inhibitor to reduce myocardial injury during acute myocardial infarction | |
Eidemak et al. | Intravenous versus subcutaneous administration of recombinant human erythropoietin in patients on haemodialysis and CAPD | |
EP0124018B1 (en) | Pharmaceutical preparation containing purified fibronectin | |
KR100255095B1 (en) | Therapeutic agent for threatened abortion | |
US4568543A (en) | Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of myocardial infarction | |
RU93049093A (en) | METHOD OF SAFE INTRAVAL INTRODUCTION OF FATTY ACIDS, METHOD OF APPLICATION OF FATTY ACIDS FOR TREATMENT OF CANCER AND OTHER DISEASES | |
US5380710A (en) | Pharmaceutical compositions containing ACTH (1-24) for the therapy of shock conditions and respiratory and cardiocirculatory insufficiences | |
Stanley et al. | Streptozotocin treatment of malignant islet cell tumour. | |
Janzing et al. | Intrapleural quinacrine instillation for recurrent pneumothorax or persistent air leak | |
NO933017L (en) | Procedure for the safe administration of fatty acid | |
US6395717B1 (en) | Therapeutic drug for endotoxin blood symptom and multi-organ failure induced thereby | |
US5554150A (en) | Granulocyte colony-stimulating factor solution delivery method | |
WO1992020361A1 (en) | New combination of factor viii and an antifibrinolytic | |
US4794104A (en) | Pharmaceutical compositions containing ACTH fragments for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies | |
JPH07502989A (en) | Treatment of hemophilia | |
Alexander | Some immunologically based reactions that can cause the regression of large tumor masses | |
US20040228852A1 (en) | Use of increased molecular-weight hirudin as an anticoagulant in extracorporeal kidney replace therapy | |
CA2170739C (en) | Method to reduce myocardial injury during acute myocardial infarction | |
JPH0251405B2 (en) | ||
US4885288A (en) | Pharmaceutical compositions containing lysine acetylsalicylate | |
Kamilah et al. | Combination Therapy of Topical Antioxidant Gel and Platelet-Rich Plasma (PRP) in Pyoderma Gangrenosum Ulcer: A Case Report | |
Hladovec et al. | Heparan sulfate as a venostatic endothelial stabilizing factor | |
ADAMI et al. | Vascular access in bone marrow transplantation (BMT) |